This project is no longer open for submissions.
Overview:
Suntory Global Innovation Center, which is responsible for the basic research of the Suntory Group, is looking for a device (or technology) that can measure the absolute value of cerebral blood flow.
————————————————————————————————————
Background:
At Suntory Global Innovation Center it is necessary to measure changes in blood flow when conducting long-term intervention tests on various ingredients related to dementia prevention etc. Magnetoencephalograph cannot measure blood flow. As fNIRS can only obtain relative values, long-term blood flow improvement (change in blood flow after a long period of time) cannot be observed. Since CT uses radioactive substances, it provides burden on human body. ASL can measure the absolute value of blood flow non-invasively, but there is a problem with accuracy.
Therefore, Suntory Global Innovation Center is looking for a device or technology that can measure the absolute value of the blood flow of the brain non-invasively and accurately.
————————————————————————————————————
Constraints:
- Ability to measure the absolute value of cerebral blood flow with high accuracy (reproducible)
- (Changes in cerebral blood flow can be measured with long-term intervention)
- Non-invasive
- The actual machine is sold (or there is a prototype with which we can confirm it works.)
- The technology can distinguish between signals of skin blood flow of scalp and that of cerebral blood flow.
- Can be used for intervention test in Japan
- It is better to measure blood flow at deeper part of the brain.
- If there is no radiation exposure or non-invasive techniques, tracer can be used.
- Technology that can measure amyloid β release from brain can also be considered
————————————————————————————————————
Desired Timeframe:
Within 12 months
————————————————————————————————————
Field of use and intended applications:
Medical equipment, pharmaceutical etc.
————————————————————————————————————
Constraints:
- Can be used for intervention test in Japan
- It is better to measure blood flow at deeper part of the brain.
- If there is no radiation exposure or non-invasive techniques, tracer can be used.
- Technology that can measure amyloid β release from brain can also be considered
————————————————————————————————————
Field of use and intended applications:
Intervention test